3R21 image
Deposition Date 2011-03-11
Release Date 2011-08-10
Last Version Date 2023-09-13
Entry Detail
PDB ID:
3R21
Title:
Design, synthesis, and biological evaluation of pyrazolopyridine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (Part I)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.90 Å
R-Value Free:
0.30
R-Value Work:
0.25
R-Value Observed:
0.26
Space Group:
P 61 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Serine/threonine-protein kinase 6
Gene (Uniprot):AURKA
Mutations:T287D, T288D
Chain IDs:A
Chain Length:271
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Design, synthesis, and biological evaluation of pyrazolopyrimidine-sulfonamides as potent multiple-mitotic kinase (MMK) inhibitors (part I).
Bioorg.Med.Chem.Lett. 21 5633 5637 (2011)
PMID: 21798738 DOI: 10.1016/j.bmcl.2011.06.129

Abstact

A novel class of pyrazolopyrimidine-sulfonamides was discovered as selective dual inhibitors of aurora kinase A (AKA) and cyclin-dependent kinase 1 (CDK1). These inhibitors were originally designed based on an early lead (compound I). SAR development has led to the discovery of potent inhibitors with single digit nM IC(50)s towards both AKA and CDK1. An exemplary compound 1a has demonstrated good efficacy in an HCT116 colon cancer xenograft model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures